Omics-Based Clinical Trials Global Market Report 2025

Name: Omics-Based Clinical Trials Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Download Sample Buy Report

Global Omics-Based Clinical Trials Market Report 2025

Omics-Based Clinical Trials Global Market Report 2025 - By Type (Genomics, Proteomics, Metabolomics, Transcriptomics), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Studies, Observational Studies, Expanded Access Studies), By Application (Oncology, Cardiovascular, Neurology, Infectious Diseases, Metabolic Disorders), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals And Diagnostic Laboratories) - Market Size, Trends, And Global Forecast 2025-2034

Omics-Based Clinical Trials Global Market Report 2025

Report Price : $4490.00 | Pages : 250 | Published : September 2025 | Delivery Time: 2-3 business days | Format :

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Regional Data

FAQs

Omics-Based Clinical Trials Global Market Report 2025

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Omics-Based Clinical Trials Market Overview

• Omics-Based Clinical Trials market size has reached to $29.10 billion in 2024

• Expected to grow to $44.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%

• Growth Driver: Rising Demand For Personalized Medicine Accelerates Growth Of The Market Due To Genomic Advancements And Targeted Treatment Approaches

• Market Trend: Advancements In HiFi Sequencing Boosting Trial Precision

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Omics-Based Clinical Trials Market?

Omics-based clinical trials refer to clinical studies that incorporate omics technologies such as genomics, proteomics, transcriptomics, metabolomics, and epigenomics to understand disease mechanisms, identify biomarkers, predict therapeutic responses, and personalize medical treatments. These trials use high-throughput data from biological molecules to guide patient selection, stratification, and treatment optimization, ultimately aiming to improve outcomes and reduce adverse effects through precision medicine approaches.

The main types of omics-based clinical trials are genomics, proteomics, metabolomics, and transcriptomics. Genomics focuses on analyzing an organism’s entire DNA sequence to understand gene structure, function, and their role in health and disease. These trials progress through phases such as phase I, phase II, phase III, and phase IV and typically follow study designs such as interventional studies, observational studies, and expanded access studies. They are widely applied in areas such as oncology, cardiovascular, neurology, infectious diseases, and metabolic disorders, and cater to several end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs), and hospitals and diagnostic laboratories.

Omics-Based Clinical Trials Market Size and growth rate 2025 to 2029: Graph

What Is The Omics-Based Clinical Trials Market Size 2025 And Growth Rate?

What Is The Omics-Based Clinical Trials Market Growth Forecast?

The omics-based clinical trials market size is expected to see strong growth in the next few years. It will grow to $44.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of multi-omics approaches, growing prevalence of chronic and rare diseases, rising investment in genomic research and biotechnology, and growing focus on biomarker discovery. Major trends in the forecast period include advancements in next-generation sequencing (NGS) technologies, integration of artificial intelligence with omics platforms, technological developments in bioinformatics tools, advancements in proteomics and metabolomics platforms, and integration of multi-omics data.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Omics-Based Clinical Trials Market Segmented?

1) By Type: Genomics, Proteomics, Metabolomics, Transcriptomics

2) By Phase: Phase I, Phase II, Phase III, Phase IV

3) By Study Design: Interventional Studies, Observational Studies, Expanded Access Studies

4) By Application: Oncology, Cardiovascular, Neurology, Infectious Diseases, Metabolic Disorders

5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals And Diagnostic Laboratories

Subsegments:

1) By Genomics: Whole Genome Sequencing, whole exome sequencing, Targeted Gene Sequencing

2) By Proteomics: Protein Expression Profiling, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping

3) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Metabolic Flux Analysis

4) By Transcriptomics: Microarray Analysis, Single-Cell Transcriptomics, Gene Expression Profiling

What Is Driving The Omics-Based Clinical Trials Market? Rising Demand For Personalized Medicine Accelerates Growth Of The Market Due To Genomic Advancements And Targeted Treatment Approaches

The increasing demand for personalized medicine is expected to propel the growth of the omics-based clinical trials market going forward. Personalized medicine refers to a medical approach that tailors disease prevention, diagnosis, and treatment to the individual characteristics of each patient. Personalized medicine demand is rising due to advances in genomic technologies that allow for faster, cost-effective analysis of individual genetic profiles to guide targeted treatments. Omics-based clinical trials support personalized medicine by enabling the identification of individual genetic, proteomic, and metabolic profiles, thereby allowing for more targeted and effective treatment strategies tailored to each patient. For instance, in February 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines represented approximately 34% of all newly approved therapies, indicating a substantial increase from previous years. Therefore, the increasing demand for personalized medicine is driving the growth of the omics-based clinical trials industry.

Who Are The Major Players In The Global Omics-Based Clinical Trials Market?

Major companies operating in the omics-based clinical trials market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., GlaxoSmithKline Plc, Eli Lilly and Company, Novo Nordisk A/S, BioNTech SE, IQVIA Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, SGS Société Générale de Surveillance SA, Eurofins Scientific SE, Syneos Health Inc., Illumina Inc., Charles River Laboratories International Inc., Parexel International Corporation, Bruker Corporation, Fulgent Genetics Inc., Signios Biosciences, and BioAro Inc.

What Are The Key Trends Of The Global Omics-Based Clinical Trials Market? Advancements In HiFi Sequencing Boosting Trial Precision

Major companies operating in the omics-based clinical trials market are focusing on innovative solutions, such as HiFi sequencing technology, to enhance the accuracy, speed, and depth of multi-omics data analysis, ultimately improving trial outcomes and personalized treatment strategies. HiFi sequencing refers to a next-generation sequencing (NGS) technology that produces long, highly accurate reads using circular consensus sequencing (CCS), enabling comprehensive and precise analysis of genomes, transcriptomes, and epigenomes. For instance, in October 2024, Pacific Biosciences of California Inc., a US-based biotechnology company, in collaboration with the Agency for Science, Technology, and Research (A*STAR), a Singapore-based research and product development agency, and Macrogen Inc., a South Korea-based biotechnology company, launched a state-of-the-art lab to accelerate genomics innovation in Singapore with cutting-edge long-read sequencing technology. The facility enables researchers to conduct advanced genomic studies with greater precision and speed. It supports a wide range of applications, including whole genome sequencing, transcriptomics, epigenetics, and metagenomics. The lab also fosters collaboration among global scientists and local institutions, aiming to accelerate discoveries in personalized medicine, rare disease diagnostics, and precision oncology. Additionally, it offers training programs and shared access to high-throughput sequencing infrastructure, promoting capacity-building and innovation within the Asia-Pacific region.

What Are Latest Mergers And Acquisitions In The Omics-Based Clinical Trials Market? Bruker Corporation Acquired Biocrates Life Sciences To Strengthen Multiomics Solutions In Clinical Research

In June 2025, Bruker Corporation, a US-based manufacturer of scientific instruments and diagnostic tests, acquired Biocrates Life Sciences AG for an undisclosed amount. With this acquisition, Bruker Corporation aims to enhance its multiomics solutions by integrating Biocrates mass spectrometry-based metabolomics technologies to deliver standardized, reproducible, and comprehensive quantitative workflows for life sciences and clinical research. Biocrates Life Sciences AG is an Austria-based biotechnology company that offers omics-based clinical trial solutions.

What Is The Regional Outlook For The Global Omics-Based Clinical Trials Market?

North America was the largest region in the omics-based clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Omics-Based Clinical Trials Market?

The omics-based clinical trials market consists of revenues earned by entities by providing services such as genomics analysis, transcriptomics profiling, proteomics studies, and metabolomics assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The omics-based clinical trials market also includes sales of next-generation sequencing (NGS) platforms, mass spectrometry instruments, microarrays, bioinformatics software, reagents, and kits. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Omics-Based Clinical Trials Industry?

The omics-based clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the omics-based clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author: Abdul Wasay

Omics Based Clinical Trials Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$31.71 billion
Revenue Forecast In 2034	$44.08 billion
Growth Rate	CAGR of 8.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Phase, Study Design, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., GlaxoSmithKline Plc, Eli Lilly and Company, Novo Nordisk A/S, BioNTech SE, IQVIA Inc., Laboratory Corporation of America Holdings, ICON Public Limited Company, SGS Société Générale de Surveillance SA, Eurofins Scientific SE, Syneos Health Inc., Illumina Inc., Charles River Laboratories International Inc., Parexel International Corporation, Bruker Corporation, Fulgent Genetics Inc., Signios Biosciences, and BioAro Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Omics-Based Clinical Trials Market Characteristics

3. Omics-Based Clinical Trials Market Trends And Strategies

4. Omics-Based Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Omics-Based Clinical Trials Growth Analysis And Strategic Analysis Framework

5.1. Global Omics-Based Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Omics-Based Clinical Trials Market Growth Rate Analysis

5.4. Global Omics-Based Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Omics-Based Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Omics-Based Clinical Trials Total Addressable Market (TAM)

6. Omics-Based Clinical Trials Market Segmentation

6.1. Global Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Genomics

Proteomics

Metabolomics

Transcriptomics

6.2. Global Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Phase I

Phase II

Phase III

Phase IV

6.3. Global Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Interventional Studies

Observational Studies

Expanded Access Studies

6.4. Global Omics-Based Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Cardiovascular

Neurology

Infectious Diseases

Metabolic Disorders

6.5. Global Omics-Based Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Academic And Research Institutes

Contract Research Organizations (CROs)

Hospitals And Diagnostic Laboratories

6.6. Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Genome Sequencing

Whole Exome Sequencing

Targeted Gene Sequencing

6.7. Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Expression Profiling

Post-Translational Modifications Analysis

Protein-Protein Interaction Mapping

6.8. Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Targeted Metabolomics

Untargeted Metabolomics

Metabolic Flux Analysis

6.9. Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Microarray Analysis

Single-Cell Transcriptomics

Gene Expression Profiling

7. Omics-Based Clinical Trials Market Regional And Country Analysis

7.1. Global Omics-Based Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Omics-Based Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Omics-Based Clinical Trials Market

8.1. Asia-Pacific Omics-Based Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Omics-Based Clinical Trials Market

9.1. China Omics-Based Clinical Trials Market Overview

9.2. China Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Omics-Based Clinical Trials Market

10.1. India Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Omics-Based Clinical Trials Market

11.1. Japan Omics-Based Clinical Trials Market Overview

11.2. Japan Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Omics-Based Clinical Trials Market

12.1. Australia Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Omics-Based Clinical Trials Market

13.1. Indonesia Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Omics-Based Clinical Trials Market

14.1. South Korea Omics-Based Clinical Trials Market Overview

14.2. South Korea Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Omics-Based Clinical Trials Market

15.1. Western Europe Omics-Based Clinical Trials Market Overview

15.2. Western Europe Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Omics-Based Clinical Trials Market

16.1. UK Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Omics-Based Clinical Trials Market

17.1. Germany Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Omics-Based Clinical Trials Market

18.1. France Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Omics-Based Clinical Trials Market

19.1. Italy Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Omics-Based Clinical Trials Market

20.1. Spain Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Omics-Based Clinical Trials Market

21.1. Eastern Europe Omics-Based Clinical Trials Market Overview

21.2. Eastern Europe Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Omics-Based Clinical Trials Market

22.1. Russia Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Omics-Based Clinical Trials Market

23.1. North America Omics-Based Clinical Trials Market Overview

23.2. North America Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Omics-Based Clinical Trials Market

24.1. USA Omics-Based Clinical Trials Market Overview

24.2. USA Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Omics-Based Clinical Trials Market

25.1. Canada Omics-Based Clinical Trials Market Overview

25.2. Canada Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Omics-Based Clinical Trials Market

26.1. South America Omics-Based Clinical Trials Market Overview

26.2. South America Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Omics-Based Clinical Trials Market

27.1. Brazil Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Omics-Based Clinical Trials Market

28.1. Middle East Omics-Based Clinical Trials Market Overview

28.2. Middle East Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Omics-Based Clinical Trials Market

29.1. Africa Omics-Based Clinical Trials Market Overview

29.2. Africa Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Omics-Based Clinical Trials Market Competitive Landscape And Company Profiles

30.1. Omics-Based Clinical Trials Market Competitive Landscape

30.2. Omics-Based Clinical Trials Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

31. Omics-Based Clinical Trials Market Other Major And Innovative Companies

31.1. Novo Nordisk A/S

31.2. BioNTech SE

31.3. IQVIA Inc.

31.4. Laboratory Corporation of America Holdings

31.5. ICON Public Limited Company

31.6. SGS Société Générale de Surveillance SA

31.7. Eurofins Scientific SE

31.8. Syneos Health Inc.

31.9. Illumina Inc.

31.10. Charles River Laboratories International Inc.

31.11. Parexel International Corporation

31.12. Bruker Corporation

31.13. Fulgent Genetics Inc.

31.14. Signios Biosciences

31.15. BioAro Inc.

32. Global Omics-Based Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Omics-Based Clinical Trials Market

34. Recent Developments In The Omics-Based Clinical Trials Market

35. Omics-Based Clinical Trials Market High Potential Countries, Segments and Strategies

35.1 Omics-Based Clinical Trials Market In 2029 - Countries Offering Most New Opportunities

35.2 Omics-Based Clinical Trials Market In 2029 - Segments Offering Most New Opportunities

35.3 Omics-Based Clinical Trials Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Omics-Based Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Omics-Based Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Omics-Based Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Omics-Based Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Pfizer Inc. Financial Performance

Table 81: F. Hoffmann-La Roche Ltd. Financial Performance

Table 82: Thermo Fisher Scientific Inc. Financial Performance

Table 83: GlaxoSmithKline Plc Financial Performance

Table 84: Eli Lilly and Company Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Omics-Based Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Omics-Based Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Metabolomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Omics-Based Clinical Trials Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Omics-Based Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Omics-Based Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Omics-Based Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Omics-Based Clinical Trials Market, Segmentation By Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Omics-Based Clinical Trials Market, Segmentation By Study Design, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Pfizer Inc. Financial Performance

Figure 81: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 82: Thermo Fisher Scientific Inc. Financial Performance

Figure 83: GlaxoSmithKline Plc Financial Performance

Figure 84: Eli Lilly and Company Financial Performance

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Key Market Drivers, Trends, and Forecast for the Global Continence Care Industry

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Photodynamic Therapy Market 2022 – By Product (Drugs, Devices), By Application (Actinic Keratosis (AK), Cancer, Acne, Psoriasis), By End-User (Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers), And By Region, Opportunities And Strategies – Global Forecast To 2031

View Report

SOC as a Service Global Market Report 2025 – By Service Type (Vulnerability Assessment And Threat Detection, Incident Response), By Component (Professional Services, Solution), By Offering Type (Fully Managed, Co-Managed), By Application (Endpoint Security, Network Security, Cloud Security, Other Applications), By Verticals (Banking, Financial Services And Insurance (BFSI), Information Technology (IT) And Information Technology Enabled Services (ITeS), Manufacturing, Telecommunications, Government And Public Sector, Healthcare And Life Sciences, Transportation And Logistics, Energy And Utilities, Other Verticals) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Injection Molding Polyamide 6 Global Market Report 2025 – By Grade (Reinforced PA 6, Unreinforced PA 6, Other Grades), By End User (Automotive, Electrical And Electronics, Industrial Or Machinery, Consumer Goods And Appliances, Construction, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Polyurethane Global Market Report 2025 – By Product Type (Coatings, Adhesives and sealants, Flexible and rigid foams, Elastomers, Other Product Types), By Raw Material (MDI, TDI, Polyols), By End User Industry (Furniture, Construction, Electronics & Appliances, Automotive, Footwear, Other End Use Industries) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Hospital Lights Global Market Report 2025 – By Product( Troffers, Surface-Mounted Lights, Surgical Lamps, Other Products ), By Technology( Fluorescent, LED, Renewable Energy, Other Technologies ), By Application( Patient Wards And ICUs, Surgical Suites, Examination Rooms, Other Applications ) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Location Analytics Global Market Report 2025 – By Location Type (Outdoor Location, Indoor Location), By Component (Solutions, Services), By Deployment Mode (On Premise, Cloud), By Application (Risk Management, Customer Experience Management, Remote Monitoring, Supply Chain Planning and Optimization, Emergency Response Management, Location Selection And Optimization, Other Applications), By Industry Vertical (Transportation And Logistics, Retail, BFSI, IT And Telecommunication, Healthcare, Energy and Utilities, Manufacturing, Other Industry Verticals) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Non-Protein Nitrogen Global Market Report 2025 – By Type (Urea, Biuret, Ammonia, Other Types), By Form (Dry, Liquid, Pellets), By Livestock (Swine, Poultry, Cattle, Aquaculture, Other Livestock) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

View Report

Light Towers Market 2023 – By Product (Stationery, Mobile), By Fuel Type (Solar or Hybrid, Diesel, Direct Power), By Technology (Manual Lifting, Hydraulic Lifting), By Lighting (Metal Halide, LED, Electric), By End User (Oil and Gas, Mining, Construction, Events and Sports, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Frequently Asked Questions

What is the definition of the Omics Based Clinical Trials market?

How will the Omics Based Clinical Trials market drivers and restraints affect the market dynamics? What forces will shape the Omics Based Clinical Trials industry going forward?

The market major growth driver - Rising Demand For Personalized Medicine Accelerates Growth Of The Market Due To Genomic Advancements And Targeted Treatment Approaches. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Omics Based Clinical Trials market?

The omics-based clinical trials market size has grown strongly in recent years. It will grow from $29.10 billion in 2024 to $31.71 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to the rising number of clinical trials involving omics technologies, the growing emphasis on translational research, increasing government support and funding, the growing availability of biobanks and biospecimens, and increasing awareness about the benefits of precision therapies. The omics-based clinical trials market size is expected to see strong growth in the next few years. It will grow to $44.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of multi-omics approaches, growing prevalence of chronic and rare diseases, rising investment in genomic research and biotechnology, and growing focus on biomarker discovery. Major trends in the forecast period include advancements in next-generation sequencing (NGS) technologies, integration of artificial intelligence with omics platforms, technological developments in bioinformatics tools, advancements in proteomics and metabolomics platforms, and integration of multi-omics data. For further insights on this market, request a sample here

How is the Omics Based Clinical Trials market segmented?

The omics-based clinical trials market covered in this report is segmented
1) By Type: Genomics, Proteomics, Metabolomics, Transcriptomics
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Study Design: Interventional Studies, Observational Studies, Expanded Access Studies
4) By Application: Oncology, Cardiovascular, Neurology, Infectious Diseases, Metabolic Disorders
5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals And Diagnostic Laboratories Subsegments:
1) By Genomics: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing
2) By Proteomics: Protein Expression Profiling, Post-Translational Modifications Analysis, Protein-Protein Interaction Mapping
3) By Metabolomics: Targeted Metabolomics, Untargeted Metabolomics, Metabolic Flux Analysis
4) By Transcriptomics: Microarray Analysis, Single-Cell Transcriptomics, Gene Expression Profiling For further insights on this market, request a sample here

Which region has the largest share of the Omics Based Clinical Trials market? What are the other regions covered in the report?

North America was the largest region in the omics-based clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the omics-based clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Omics Based Clinical Trials market?

What are the key trends in the Omics Based Clinical Trials market?

Major trends in this market include Advancements In HiFi Sequencing Boosting Trial Precision. For further insights on this market, request a sample here.

Omics-Based Clinical Trials Global Market Report 2025

Omics-Based Clinical Trials Global Market Report 2025

Market Insights

Related Reports

Omics-Based Clinical Trials Market Overview

What Is Covered Under Omics-Based Clinical Trials Market?

What Is The Omics-Based Clinical Trials Market Size 2025 And Growth Rate?

What Is The Omics-Based Clinical Trials Market Growth Forecast?

What’s The Trade War Impact On Healthcare Services Industry?

How Is The Omics-Based Clinical Trials Market Segmented?

What Is Driving The Omics-Based Clinical Trials Market? Rising Demand For Personalized Medicine Accelerates Growth Of The Market Due To Genomic Advancements And Targeted Treatment Approaches

Who Are The Major Players In The Global Omics-Based Clinical Trials Market?

What Are The Key Trends Of The Global Omics-Based Clinical Trials Market? Advancements In HiFi Sequencing Boosting Trial Precision

What Are Latest Mergers And Acquisitions In The Omics-Based Clinical Trials Market? Bruker Corporation Acquired Biocrates Life Sciences To Strengthen Multiomics Solutions In Clinical Research

What Is The Regional Outlook For The Global Omics-Based Clinical Trials Market?

What Defines the Omics-Based Clinical Trials Market?

How is Market Value Defined and Measured?

What is the Market Assessment and Strategic Outlook for the Omics-Based Clinical Trials Industry?

Table Of Contents

List Of Tables

List Of Figures

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Key Market Drivers, Trends, and Forecast for the Global Continence Care Industry

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Photodynamic Therapy Market 2022 – By Product (Drugs, Devices), By Application (Actinic Keratosis (AK), Cancer, Acne, Psoriasis), By End-User (Cosmetics And Dermatology Clinics, Hospitals, Cancer Treatment Centers), And By Region, Opportunities And Strategies – Global Forecast To 2031

Non-Protein Nitrogen Global Market Report 2025 – By Type (Urea, Biuret, Ammonia, Other Types), By Form (Dry, Liquid, Pellets), By Livestock (Swine, Poultry, Cattle, Aquaculture, Other Livestock) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Frequently Asked Questions